129 related articles for article (PubMed ID: 2346534)
1. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with an omega-aminoalkyl group.
Saito S; Matsui S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 Mar; 40(3):257-60. PubMed ID: 2346534
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.
Waga T; Matsui S; Saito S; Watanabe M; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 Apr; 40(4):407-13. PubMed ID: 2162675
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives.
Saito S; Matsui S; Fukushima S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1989 Dec; 39(12):1558-61. PubMed ID: 2560371
[TBL] [Abstract][Full Text] [Related]
5. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
[TBL] [Abstract][Full Text] [Related]
6. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N-(phosphonoacetyl)-dipeptide derivatives and evaluation of their antihypertensive activity.
Osapay G; Körmöczy P; Szilágyi I; Kajtár J; Kiss B
Pharmazie; 1990 Sep; 45(9):666-8. PubMed ID: 2178265
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and biological activity of some Val(Ala)-Tyr and Val-Tyr-Tyr peptides].
Chen PL; Peng SX; Yang ZX
Yao Xue Xue Bao; 1992; 27(12):895-902. PubMed ID: 1299138
[TBL] [Abstract][Full Text] [Related]
9. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
[TBL] [Abstract][Full Text] [Related]
10. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiotensin-converting enzyme by dipeptide analogs.
Schwab A; Macerata R; Rogers W; Barton J; Skiles J; Khandwala A
Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):339-45. PubMed ID: 6095384
[TBL] [Abstract][Full Text] [Related]
12. Effect of varying chain length between P(1) and P(1') position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors.
Chaudhary S; Vats ID; Chopra M; Biswas P; Pasha S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4364-6. PubMed ID: 19523823
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Sweet CS
Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
[TBL] [Abstract][Full Text] [Related]
14. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
Li GH; Qu MR; Wan JZ; You JM
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
[TBL] [Abstract][Full Text] [Related]
16. Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
Ciabatti R; Tarzia G; Battaglia F; Barone D; Baldoli E
Farmaco Sci; 1988 Dec; 43(12):989-1003. PubMed ID: 2854788
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
18. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
Nagata S; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
